WO2004020595A3 - Novel human polypeptides encoded by polynucleotides - Google Patents
Novel human polypeptides encoded by polynucleotides Download PDFInfo
- Publication number
- WO2004020595A3 WO2004020595A3 PCT/US2003/027107 US0327107W WO2004020595A3 WO 2004020595 A3 WO2004020595 A3 WO 2004020595A3 US 0327107 W US0327107 W US 0327107W WO 2004020595 A3 WO2004020595 A3 WO 2004020595A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides
- polypeptides encoded
- novel human
- human polypeptides
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003274935A AU2003274935A1 (en) | 2002-08-29 | 2003-08-28 | Novel human polypeptides encoded by polynucleotides |
Applications Claiming Priority (68)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40665502P | 2002-08-29 | 2002-08-29 | |
US40666602P | 2002-08-29 | 2002-08-29 | |
US40661602P | 2002-08-29 | 2002-08-29 | |
US40657602P | 2002-08-29 | 2002-08-29 | |
US40661202P | 2002-08-29 | 2002-08-29 | |
US40664002P | 2002-08-29 | 2002-08-29 | |
US40661102P | 2002-08-29 | 2002-08-29 | |
US60/406,655 | 2002-08-29 | ||
US60/406,576 | 2002-08-29 | ||
US60/406,616 | 2002-08-29 | ||
US60/406,666 | 2002-08-29 | ||
US60/406,640 | 2002-08-29 | ||
US60/406,611 | 2002-08-29 | ||
US60/406,612 | 2002-08-29 | ||
US41105202P | 2002-09-17 | 2002-09-17 | |
US41095102P | 2002-09-17 | 2002-09-17 | |
US41102402P | 2002-09-17 | 2002-09-17 | |
US41108202P | 2002-09-17 | 2002-09-17 | |
US41102202P | 2002-09-17 | 2002-09-17 | |
US41096002P | 2002-09-17 | 2002-09-17 | |
US41095702P | 2002-09-17 | 2002-09-17 | |
US41095302P | 2002-09-17 | 2002-09-17 | |
US41111102P | 2002-09-17 | 2002-09-17 | |
US41094602P | 2002-09-17 | 2002-09-17 | |
US41096202P | 2002-09-17 | 2002-09-17 | |
US41104602P | 2002-09-17 | 2002-09-17 | |
US41101902P | 2002-09-17 | 2002-09-17 | |
US41103702P | 2002-09-17 | 2002-09-17 | |
US60/411,111 | 2002-09-17 | ||
US60/410,951 | 2002-09-17 | ||
US60/410,946 | 2002-09-17 | ||
US60/411,024 | 2002-09-17 | ||
US60/410,960 | 2002-09-17 | ||
US60/411,046 | 2002-09-17 | ||
US60/410,953 | 2002-09-17 | ||
US60/411,022 | 2002-09-17 | ||
US60/411,082 | 2002-09-17 | ||
US60/411,019 | 2002-09-17 | ||
US60/410,962 | 2002-09-17 | ||
US60/410,957 | 2002-09-17 | ||
US60/411,052 | 2002-09-17 | ||
US60/411,037 | 2002-09-17 | ||
US46373203P | 2003-04-18 | 2003-04-18 | |
US46370003P | 2003-04-18 | 2003-04-18 | |
US60/463,732 | 2003-04-18 | ||
US60/463,700 | 2003-04-18 | ||
US46723003P | 2003-05-02 | 2003-05-02 | |
US46720303P | 2003-05-02 | 2003-05-02 | |
US60/467,203 | 2003-05-02 | ||
US60/467,230 | 2003-05-02 | ||
US47130603P | 2003-05-19 | 2003-05-19 | |
US60,471,306 | 2003-05-19 | ||
US47242003P | 2003-05-22 | 2003-05-22 | |
US60/472,420 | 2003-05-22 | ||
US47660903P | 2003-06-09 | 2003-06-09 | |
US60/476,609 | 2003-06-09 | ||
US48532503P | 2003-07-08 | 2003-07-08 | |
US48522303P | 2003-07-08 | 2003-07-08 | |
US60/485,223 | 2003-07-08 | ||
US60/485,325 | 2003-07-08 | ||
US48648003P | 2003-07-14 | 2003-07-14 | |
US60/486,480 | 2003-07-14 | ||
US48696003P | 2003-07-15 | 2003-07-15 | |
US60/486,960 | 2003-07-15 | ||
US49357303P | 2003-08-08 | 2003-08-08 | |
US49337003P | 2003-08-08 | 2003-08-08 | |
US60/493,370 | 2003-08-08 | ||
US60/493,573 | 2003-08-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004020595A2 WO2004020595A2 (en) | 2004-03-11 |
WO2004020595A8 WO2004020595A8 (en) | 2004-07-15 |
WO2004020595A3 true WO2004020595A3 (en) | 2006-05-04 |
Family
ID=32686486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/027107 WO2004020595A2 (en) | 2002-08-29 | 2003-08-28 | Novel human polypeptides encoded by polynucleotides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004020595A2 (en) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101520209B1 (en) | 2003-11-06 | 2015-05-13 | 시애틀 지네틱스, 인크. | Monomethylvaline compounds capable of conjugation to ligands |
BRPI0510883B8 (en) | 2004-06-01 | 2021-05-25 | Genentech Inc | drug-antibody conjugate compound, pharmaceutical composition, method of manufacturing a drug-antibody conjugate compound, and uses of a formulation, a drug-antibody conjugate and a chemotherapeutic agent, and a combination |
ES2579805T3 (en) | 2004-09-23 | 2016-08-16 | Genentech, Inc. | Antibodies and conjugates engineered with cysteine |
US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
CA2650267A1 (en) * | 2006-05-05 | 2007-11-15 | Universiteit Maastricht / Carim | Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual |
EP2414836B1 (en) * | 2009-03-30 | 2014-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis |
CA2809819A1 (en) | 2009-09-09 | 2011-03-17 | Centrose, Llc | Extracellular targeted drug conjugates |
ES2430567T3 (en) | 2010-04-15 | 2013-11-21 | Spirogen Sàrl | Pyrrolobenzodiazepines and conjugates thereof |
EP2579897A1 (en) | 2010-06-08 | 2013-04-17 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
JP5889912B2 (en) | 2010-11-17 | 2016-03-22 | ジェネンテック, インコーポレイテッド | Alaninyl maytansinol antibody conjugate |
US8679767B2 (en) | 2011-05-12 | 2014-03-25 | Genentech, Inc. | Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides |
PT2750713E (en) | 2011-10-14 | 2016-01-20 | Genentech Inc | Pyrrolobenzodiazepines and conjugates thereof |
WO2013130093A1 (en) | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
AU2013328623B8 (en) | 2012-10-12 | 2017-06-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
ES2680153T3 (en) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Anti-PSMA-pyrrolobenzodiazepine antibody conjugates |
NZ707543A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
SI2906253T1 (en) | 2012-10-12 | 2018-11-30 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
ES2649990T3 (en) | 2012-10-12 | 2018-01-16 | Medimmune Limited | Anti-CD22-pyrrolobenzodiazepine antibody conjugates |
ES2530968T3 (en) | 2012-10-12 | 2015-03-09 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
CA2894961C (en) | 2012-12-21 | 2020-09-15 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
US9567340B2 (en) | 2012-12-21 | 2017-02-14 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
CN105209077B (en) | 2013-03-13 | 2019-06-11 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
CA2901941C (en) | 2013-03-13 | 2020-04-07 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
AU2014229529B2 (en) | 2013-03-13 | 2018-02-15 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
EP3033111B1 (en) | 2013-08-12 | 2019-03-13 | Genentech, Inc. | 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
WO2015052532A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
CN107106700B (en) | 2013-12-16 | 2020-10-30 | 基因泰克公司 | Peptidomimetic compounds and antibody-drug conjugates thereof |
MX2016007578A (en) | 2013-12-16 | 2016-10-03 | Genentech Inc | 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment. |
RU2689388C1 (en) | 2013-12-16 | 2019-05-28 | Дженентек, Инк. | Peptidomimetic compounds and their conjugates of antibodies with drugs |
CN106687141A (en) | 2014-09-10 | 2017-05-17 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines and conjugates thereof |
CN106714844B (en) | 2014-09-12 | 2022-08-05 | 基因泰克公司 | Anthracycline disulfide intermediates, antibody-drug conjugates and methods |
AR101844A1 (en) | 2014-09-12 | 2017-01-18 | Genentech Inc | ANTIBODIES AND GENETICALLY MODIFIED CONJUGATES WITH CYSTEINE |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
EP3194400A1 (en) | 2014-09-17 | 2017-07-26 | Genentech, Inc. | Pyrrolobenzodiazepines and antibody disulfide conjugates thereof |
CA2968447A1 (en) | 2014-11-25 | 2016-06-02 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms |
WO2016090050A1 (en) | 2014-12-03 | 2016-06-09 | Genentech, Inc. | Quaternary amine compounds and antibody-drug conjugates thereof |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
MA43345A (en) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
MA43354A (en) | 2015-10-16 | 2018-08-22 | Genentech Inc | CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE |
MA45326A (en) | 2015-10-20 | 2018-08-29 | Genentech Inc | CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
EP4273551A3 (en) | 2016-03-25 | 2024-01-17 | F. Hoffmann-La Roche AG | Multiplexed total antibody and antibody-conjugated drug quantification assay |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
WO2017201449A1 (en) | 2016-05-20 | 2017-11-23 | Genentech, Inc. | Protac antibody conjugates and methods of use |
JP7022080B2 (en) | 2016-05-27 | 2022-02-17 | ジェネンテック, インコーポレイテッド | Biochemical analytical methods for the characterization of site-specific antibody-drug conjugates |
JP7043425B2 (en) | 2016-06-06 | 2022-03-29 | ジェネンテック, インコーポレイテッド | Silvestrol Antibodies-Drug Conjugates and Usage |
JP7093767B2 (en) | 2016-08-11 | 2022-06-30 | ジェネンテック, インコーポレイテッド | Pyrrolobenzodiazepine prodrug and its antibody conjugate |
JP7050770B2 (en) | 2016-10-05 | 2022-04-08 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Method for preparing antibody drug conjugate |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
AU2018217926B2 (en) | 2017-02-08 | 2019-10-03 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
JP2020517609A (en) | 2017-04-18 | 2020-06-18 | メディミューン リミテッド | Pyrrolobenzodiazepine complex |
EP3612234B1 (en) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Combination therapy with an anti-axl antibody-drug conjugate |
US11318211B2 (en) | 2017-06-14 | 2022-05-03 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-CD19 ADC |
SI3668874T1 (en) | 2017-08-18 | 2022-04-29 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
US20200216463A1 (en) | 2017-09-20 | 2020-07-09 | Ph Pharma Co., Ltd. | Thailanstatin analogs |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
WO2020086858A1 (en) | 2018-10-24 | 2020-04-30 | Genentech, Inc. | Conjugated chemical inducers of degradation and methods of use |
CN113227119A (en) | 2018-12-10 | 2021-08-06 | 基因泰克公司 | Photocrosslinked peptides for site-specific conjugation to Fc-containing proteins |
KR102351041B1 (en) * | 2018-12-19 | 2022-01-13 | 한국화학연구원 | Cell penetrating Domain derived from human LRRC24 protein |
GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
CN111259667A (en) * | 2020-01-16 | 2020-06-09 | 上海国民集团健康科技有限公司 | Chinese medicine word segmentation algorithm |
GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
WO2024138128A2 (en) | 2022-12-23 | 2024-06-27 | Genentech, Inc. | Cereblon degrader conjugates, and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365344B1 (en) * | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6426186B1 (en) * | 2000-01-18 | 2002-07-30 | Incyte Genomics, Inc | Bone remodeling genes |
-
2003
- 2003-08-28 WO PCT/US2003/027107 patent/WO2004020595A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365344B1 (en) * | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6426186B1 (en) * | 2000-01-18 | 2002-07-30 | Incyte Genomics, Inc | Bone remodeling genes |
Also Published As
Publication number | Publication date |
---|---|
WO2004020595A8 (en) | 2004-07-15 |
WO2004020595A2 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004020595A3 (en) | Novel human polypeptides encoded by polynucleotides | |
WO2004035732A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
IL161016A (en) | Polypeptides capable of binding to ang-2 | |
WO2002024909A3 (en) | Receptor nucleic acids and polypeptides | |
EP1005540A4 (en) | Ikk-beta proteins, nucleic acids and methods | |
HK1120556A1 (en) | Neurotrophic factors | |
WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
WO2003018758A3 (en) | Reagents and methods for smooth muscle therapies | |
WO2004093804A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
WO2007087053A3 (en) | Bmp-7 variant compositions, methods and uses | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
MXPA03006218A (en) | Type 2 ctokine receptor and nucleic acids encoding same. | |
WO2005085280A3 (en) | HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE | |
WO2004094651A3 (en) | Novel human polypeptides encoded by polynucleotides | |
WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
WO2004038003A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
WO2005037236A3 (en) | Novel heat shock protein 20-related polypeptides and uses therefor | |
WO2003055980A3 (en) | Il-17 like molecules and uses thereof | |
WO2004039952A8 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
WO2004039319A3 (en) | Novel human polypeptides encoded by polynucleotides | |
WO2004046310A3 (en) | Novel mouse polypeptides encoded by polynucleotides and methods of their use | |
WO2004078130A3 (en) | Posh interacting proteins and related methods | |
WO2004089302A3 (en) | Posh polypeptides, complexes and related methods | |
WO2002072632A3 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 11/2004 UNDER (30) ADD "60/463,732 18 APRIL 2003 (18.04.2003) US; 60/463,700 18 APRIL 2003 (18.04.2003) US; 60/467,230 02 MAY 2003 (02.05.2003) US; 60/467,203 02 MAY 2003 (02.05.2003) US; 60/471,306 19 MAY 2003 (19.05.2003) US; 60/472,420 22 MAY 2003 (22.05.2003) US; 60/476,609 09 JUNE 2003 (09.06.2003) US; 60/485,223 08 JULY 2003 (08.07.2003) US; 60/485,325 08 JULY 2003 (08.07.2003) US; 60/486,480 14 JULY 203 (14.07.2003) US; 60/486,960 15 JULY 2003 (15.07.2003) US; 60/493,573 08 AUGUST 2003 (08.08.2003) US; 60/493,370 08 AUGUST 2003 (08.08.2003) US" |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |